ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.136,84
0,35%
S&P 500
5.473,23
0,77%
Dow Jones
38.778,10
0,49%
Euro vs US Dollar
1,07236
-0,16%
Bitcoin
65.461,36
-1,54%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Larimar Therapeutics Inc (LRMR)

  7. Larimar Therapeutics Inc (LRMR) News

LRMR

Larimar Therapeutics (LRMR)

Larimar Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:LRMR
DatumZeitQuelleÜberschriftSymbolFirma
10/06/202412h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
31/05/202422h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
31/05/202422h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
31/05/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
30/05/202422h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
28/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LRMRLarimar Therapeutics Inc
20/05/202422h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
09/05/202422h50Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LRMRLarimar Therapeutics Inc
09/05/202413h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
11/03/202421h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
16/02/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
15/02/202402h57Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LRMRLarimar Therapeutics Inc
14/02/202423h08Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LRMRLarimar Therapeutics Inc
14/02/202414h55Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LRMRLarimar Therapeutics Inc
14/02/202412h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
13/02/202422h46Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LRMRLarimar Therapeutics Inc
12/02/202413h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
19/01/202422h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
19/01/202422h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
19/01/202422h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
19/01/202422h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
08/12/202322h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
14/11/202319h51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LRMRLarimar Therapeutics Inc
03/10/202322h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
14/08/202314h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
10/08/202322h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LRMRLarimar Therapeutics Inc
10/08/202313h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
25/07/202319h06Dow Jones NewsLarimar Therapeutics Shares Rise 10% After FDA Clears CTI-1601 TrialNASDAQ:LRMRLarimar Therapeutics Inc
25/07/202313h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
18/07/202322h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:LRMR

Kürzlich von Ihnen besucht

FX
EURJPY
Euro vs Yen
AMEX
XLV
Health Care Select Sector
FX
EURUSD
Euro vs US Dollar
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
NVDA
NVIDIA
TG
ALV
Allianz
AMEX
SPY
SPDR S&P 500
NYSE
NKE
Nike
NYSE
MRK
Merck
NASDAQ
AAPL
Apple
DBI
MDAX
MDAX
COIN
SOLUSD
Solana
TG
TUI1
Tui
DBI
SDXP
SDAX
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten